Bevacizumab/ranibizumab/verteporfinGeographic atrophy: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2015年 / 1536卷 / 1期

关键词：

D O I：

10.1007/s40278-015-6902-7

中图分类号：

学科分类号：

摘要：

引用

下载

收藏

页码：49 / 49

相关论文

共 50 条

[41] Bevacizumab/corticosteroidsOsteonecrosis: 3 case reports
Reactions Weekly, 2013, 1444 (1) : 11 - 11
[42] Bevacizumab/ranibizumabEndophthalmitis: 3 case reports
Reactions Weekly, 2015, 1576 (1) : 61 - 61
[43] Bevacizumab/ranibizumabEndophthalmitis: 16 case reports
Reactions Weekly, 2016, 1592 (1) : 49 - 49
[44] Bevacizumab/dexamethasoneEndophthalmitis: 5 case reports
Reactions Weekly, 2017, 1653 (1) : 73 - 73
[45] Ranibizumab and Bevacizumab: equally good?
Bitzer, Michaela
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2014, 231 (03) : 194 - 195
[46] Bevacizumab versus ranibizumab: A draw?
Souied, E. H.
Cohen, S. Y.
Kodjikian, L.
JOURNAL FRANCAIS D OPHTALMOLOGIE, 2012, 35 (02): : 79 - 81
[47] Bevacizumab/carboplatin/gemcitabineHaemolytic uraemic syndrome in elderly patients: 4 case reports
Reactions Weekly, 2014, 1494 (1) : 13 - 13
[48] Ranibizumab and Bevacizumab for AMD REPLY
Martin, Daniel F.
Maguire, Maureen G.
Fine, Stuart L.
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (23): : 2237 - 2237
[49] Bevacizumab/cetuximab/irinotecanDevelopment of chemotherapy resistance and disease progression: 4 case reports
Reactions Weekly, 2015, 1533 (1) : 87 - 87
[50] Pegaptanib/ranibizumab/triamcinoloneEndophthalmitis and uveitis: 11 case reports
Reactions Weekly, 2013, 1433 (1) : 33 - 33

← 1 2 3 4 5 →